ticlopidine has been researched along with Osteogenesis Imperfecta in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Osteogenesis Imperfecta: COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajsadeghi, S | 1 |
| Jafarian Kerman, SR | 1 |
| Pouraliakbar, H | 1 |
| Mohammadi, R | 1 |
1 other study available for ticlopidine and Osteogenesis Imperfecta
| Article | Year |
|---|---|
A huge coronary artery aneurysm in osteogenesis imperfecta: a case report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Aneurysm; Drug Therap | 2012 |